These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38888250)

  • 1. Retrospective evaluation of the effect of acid suppressant drugs on leukocyte ratios in dogs with mast cell tumors.
    Oberholtzer S; Zhu X; Dedeaux A; Martin O; Gould EN
    J Vet Intern Med; 2024; 38(4):2305-2315. PubMed ID: 38888250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
    Tomita T; Kim Y; Yamasaki T; Okugawa T; Kondo T; Toyoshima F; Sakurai J; Tanaka J; Morita T; Oshima T; Fukui H; Hori K; Watari J; Matsumoto T; Miwa H
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1441-6. PubMed ID: 22497427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gastric acid-suppressive therapy and biological variation of serum gastrin concentrations in dogs with chronic enteropathies.
    Heilmann RM; Berghoff N; Grützner N; Parnell NK; Suchodolski JS; Steiner JM
    BMC Vet Res; 2017 Nov; 13(1):321. PubMed ID: 29115998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
    Sakurada T; Kawashima J; Ariyama S; Kani K; Takabayashi H; Ohno S; Kato S; Yakabi K
    Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs.
    Bersenas AM; Mathews KA; Allen DG; Conlon PD
    Am J Vet Res; 2005 Mar; 66(3):425-31. PubMed ID: 15822586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study.
    Arbel Y; Birati EY; Finkelstein A; Halkin A; Kletzel H; Abramowitz Y; Berliner S; Deutsch V; Herz I; Keren G; Banai S
    Clin Cardiol; 2013 Jun; 36(6):342-6. PubMed ID: 23630016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.
    Takahashi N; Miura M; Niioka T; Sawada K
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):999-1004. PubMed ID: 22147077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of H2-blockers and proton pump inhibitors on intragastric acidity and intraesophageal pH in patients with gastroesophageal reflux disease].
    Ivanov AN; Iakovenko EP; Iakovenko AV
    Eksp Klin Gastroenterol; 2004; (4):16-20, 107. PubMed ID: 15568661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esomeprazole induces structural changes and apoptosis and alters function of in vitro canine neoplastic mast cells.
    Gould EN; Szule JA; Wilson-Robles H; Steiner JM; Lennon EM; Tolbert MK
    Vet Immunol Immunopathol; 2023 Feb; 256():110539. PubMed ID: 36592548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
    Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
    Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis.
    Kusunoki H; Kusaka M; Kido S; Yamauchi R; Fujimura Y; Watanabe Y; Kobori M; Miwa H; Tomita T; Kin Y; Hori K; Tano N; Sugimoto K; Nakamura Y; Fujimoto K; Oza N; Matsunobu A; Ono N; Fuyuno S; Kinoshita Y; Adachi K; Yuki M; Fujisawa T; Haruma K
    J Gastroenterol; 2009; 44(4):261-70. PubMed ID: 19280112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.
    Tutuian R; Katz PO; Ahmed F; Korn S; Castell DO
    Aliment Pharmacol Ther; 2002 Mar; 16(3):473-7. PubMed ID: 11876700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis?
    Soga T; Matsuura M; Kodama Y; Fujita T; Sekimoto I; Nishimura K; Yoshida S; Kutsumi H; Fujimoto S
    J Gastroenterol; 1999 Aug; 34(4):435-40. PubMed ID: 10452673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer.
    Hu FL; Jia JC; Li YL; Yang GB
    J Int Med Res; 2003; 31(6):469-74. PubMed ID: 14708410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.
    Yuki H; Kamato T; Nishida A; Fujihara A; Takeda M; Miyata K
    Jpn J Pharmacol; 1993 Nov; 63(3):345-51. PubMed ID: 7906319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy.
    Nema H; Kato M
    World J Gastroenterol; 2010 Nov; 16(42):5342-6. PubMed ID: 21072898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype status.
    Sugimoto M; Furuta T; Shirai N; Ikuma M; Hishida A; Ishizaki T
    Clin Pharmacol Ther; 2006 Nov; 80(5):539-48. PubMed ID: 17112810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.